Neurogene
NGNE
63 hedge funds and large institutions have $21.4M invested in Neurogene in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 30 closing their positions.
0.44% less ownership
Funds ownership: 2.89% → 2.45% (-0.44%)
22% less funds holding
Funds holding: 81 → 63 (-18)
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
50% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 30
57% less capital invested
Capital invested by funds: $49.7M → $21.4M (-$28.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.07M |
| 2 |
Renaissance Technologies
New York
|
+$421K |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$259K |
| 4 |
E
Ergoteles
New York
|
+$202K |
| 5 |
Two Sigma Advisers
New York
|
+$120K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$2.19M |
| 2 |
BlackRock
New York
|
-$2.01M |
| 3 |
State Street
Boston,
Massachusetts
|
-$565K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$347K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$291K |
NGNE Hedge Fund Activity: Q2 2022 in Review
63 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2022, worth a combined $21.4M — down 57% from $49.7M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of NGNE and 15 opened new positions — a net loss of 15 holders — while 22 trimmed existing stakes and 15 added.
The largest buyer was Millennium Management, adding an estimated $1.07M. The largest seller was Pictet Asset Management (Switzerland), cutting an estimated $2.19M.
- 63 institutional investors held Neurogene (NGNE) as of Q2 2022, down from 81 in Q1 2022.
- Funds reported $21.4M of Neurogene stock for Q2 2022, down 57% quarter-over-quarter.
- 15 funds opened new Neurogene positions in Q2 2022 and 30 closed out, a net change of -15 holders.
- The largest Neurogene buyer in Q2 2022 was Millennium Management, an estimated $1.07M added.
- The largest Neurogene seller in Q2 2022 was Pictet Asset Management (Switzerland), an estimated $2.19M sold.
Based on aggregated 13F filings for Q2 2022.